TNF-α is considered an inflammatory substrate for cognitive impairment in the early clinical stages of dementia (60), and studies have found that TNF-α-targeted therapies may be a biologically feasible way to maintain cognitive ability (61). Here, TNF is linked to Cognitive impairment.